Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia
Clinical trial NCT02086786 · COMPLETED
Trial details
- NCT number
- NCT02086786
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-03-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.